Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02934425 · ClinicalTrials.gov registry record · NA

Effects of Lean Pork, High Protein Breakfast on Satiety and Metabolic Health in Pre-diabetes

A NA study, sponsored by Midwest Center for Metabolic and Cardiovascular Research.

Completed
Registry status
NA
Development phase
22
Enrollment target

NCT02934425: Completed NA study, sponsored by Midwest Center for Metabolic and Cardiovascular Research.

NCT02934425 is a NA study that has completed, run by Midwest Center for Metabolic and Cardiovascular Research. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02934425, a NA study, has completed, sponsored by Midwest Center for Metabolic and Cardiovascular Research.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target

Study Summary

The goal of this study is to assess the effects of consumption of a lean pork-containing, high-protein breakfast versus a refined carbohydrate-rich breakfast on satiety and cardiometabolic parameters in overweight or obese adults with pre-diabetes.

Primary Outcome

Difference between test conditions in net incremental AUC from pre-consumption (t = -15 minutes) to t = 240 minutes for VAS ratings for appetite (fullness, hunger, desire to eat, prospective food consumption)

Interventions

  • OTHER Refined carbohydrate-rich breakfast
  • OTHER High pork protein breakfast

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2016-08
Est. Completion 2017-02
Phase NA

What the finished NCT02934425 record still lists

NCT02934425 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Refined carbohydrate-rich breakfast is the first listed.

NCT02934425 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02934425 about?

NCT02934425 is a clinical study titled "Effects of Lean Pork, High Protein Breakfast on Satiety and Metabolic Health in Pre-diabetes". The goal of this study is to assess the effects of consumption of a lean pork-containing, high-protein breakfast versus a refined carbohydrate-rich breakfast on satiety and cardiometabolic parameters in overweight or obese adults with pre-diabetes.

What is the current status of trial NCT02934425?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2016-08. Estimated completion is 2017-02.

What interventions are being tested in trial NCT02934425?

The interventions under investigation include: Refined carbohydrate-rich breakfast (OTHER), High pork protein breakfast (OTHER).

Who is sponsoring clinical trial NCT02934425?

This trial is sponsored by Midwest Center for Metabolic and Cardiovascular Research, which has 26 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02934425's enrollment target sits among peer trials

22 1756th of 2000 higher than 239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02934425, the US trial registry maintained by the National Library of Medicine. NCT02934425 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.